1
|
Santos-Hövener C, Busch MA, Koschollek C, Schlaud M, Hoebel J, Hoffmann R, Wilking H, Haller S, Allen J, Wernitz J, Butschalowsky H, Kuttig T, Stahlberg S, Strandmark J, Rosario AS, Gößwald A, Nitsche A, Hamouda O, Drosten C, Corman V, Wieler LH, Schaade L, Lampert T. Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany - Study protocol of the CORONA-MONITORING lokal study. J Health Monit 2020; 5:2-16. [PMID: 35146295 PMCID: PMC8734078 DOI: 10.25646/7053] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/28/2020] [Accepted: 08/06/2020] [Indexed: 01/04/2023]
Abstract
At a regional and local level, the COVID-19 pandemic has not spread out uniformly and some German municipalities have been particularly affected. The seroepidemiological data from these areas helps estimate the proportion of the population that has been infected with SARS-CoV-2 (seroprevalence), as well as the number of undetected infections and asymptomatic cases. In four municipalities which were especially affected, 2,000 participants will be tested for an active SARS-CoV-2 infection (oropharyngeal swab) or a past infection (blood specimen IgG antibody test). Participants will also be asked to fill out a short written questionnaire at study centres and complete a follow-up questionnaire either online or by telephone, including information on issues such as possible exposure, susceptability, symptoms and medical history. The CORONA-MONITORING lokal study will allow to determine the proportion of the population with SARS-CoV-2 antibodies in four particularly affected locations. This study will increase the accuracy of estimates regarding the scope of the epidemic, help determine risk and protective factors for an infection and therefore also identify especially exposed groups and, as such, it will be crucial towards planning of prevention measures.
Collapse
Affiliation(s)
| | - Markus A. Busch
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Carmen Koschollek
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Martin Schlaud
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Jens Hoebel
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Robert Hoffmann
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Hendrik Wilking
- Robert Koch Institute, Berlin Department of Infectious Disease Epidemiology
| | - Sebastian Haller
- Robert Koch Institute, Berlin Department of Infectious Disease Epidemiology
| | - Jennifer Allen
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Jörg Wernitz
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Hans Butschalowsky
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Tim Kuttig
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Silke Stahlberg
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Julia Strandmark
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | | | - Antje Gößwald
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| | - Andreas Nitsche
- Robert Koch Institute, Berlin Centre for Biological Threats and Special Pathogens
| | - Osamah Hamouda
- Robert Koch Institute, Berlin Department of Infectious Disease Epidemiology
| | - Christian Drosten
- Charité – UniversitätsmedizinBerlin Institute of Virology, National Consultant Laboratory for Coronaviruses
| | - Victor Corman
- Charité – UniversitätsmedizinBerlin Institute of Virology, National Consultant Laboratory for Coronaviruses
| | - Lothar H. Wieler
- Robert Koch Institute, Berlin Institute Leadership
- Robert Koch Institute, Berlin Methodology and Research Infrastructure
| | - Lars Schaade
- Robert Koch Institute, Berlin Centre for Biological Threats and Special Pathogens
- Robert Koch Institute, Berlin Institute Leadership
| | - Thomas Lampert
- Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring
| |
Collapse
|